DOST
DOST Secretary Fortunato “Boy” T. de la Peña and Undersecretary Rowena Cristina Guevara, chair of the Task Group on Vaccine Evaluation and Selection (TG-VES), cited Moderna’s filing of its EUA application before the Food and Drug Administration (FDA) on Monday, April 26.
“The more brands granted EUA by our FDA means we have more choices and bigger chances for vaccine availability,” de la Peña told the Manila Bulletin in a Viber message.
FDA Director General Eric Domingo announced that Moderna has filed its EUA application before the regulatory body on Monday, April 26.
“We have been expecting this for some time now,’ Guevara said.
Additional incentives maybe needed to attract more potential vaccine manufacturers – DOST mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
By JULIA MARI ORNEDO, GMA News
Published April 9, 2021 6:48pm The Food and Drug Administration (FDA) on Friday said it approved the use of China’s Sinovac COVID-19 vaccine on the elderly because it was “more beneficial” to the vulnerable age group than having to wait for another brand to be available in the country. FDA chief Eric Domingo admitted that while data on CoronaVac’s efficacy among the elderly is “very limited,” there are no concerns on its safety based on the monitoring of some 700 senior citizen health workers who got the Chinese-made vaccine. “No’ng tiningnan natin, ‘yung adverse events sa kanila (When we checked, the adverse events among them) are within reasonable levels, acceptable levels,” he said in a Department of Health (DOH) briefing.
DOST-led vaccine evaluation group vows to uphold public safety over COVID-19 jabs mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
(Photo by MARIO TAMA / GETTY IMAGES NORTH AMERICA / Getty Images via AFP)
DOST Secretary Fortunato “Boy” T. de la Peña and Undersecretary Rowena Cristina Guevara, chair of the Task Group on Vaccine Evaluation and Selection (TG-VES), cheered at the announcement of the Philippine Food and Drug Administration (FDA) that Janssen, which is owned by American multinational company Johnson & Johnson, filed for an EUA on March 31.
“We welcome the news of another COVID-19 vaccine applying for EUA in the Philippines. One good thing is that they did clinical trials in the Philippines the results of which only the vaccine developing company can announce,” he told the Manila Bulletin in a Viber message.